- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04320108
ESWT for Shoulder Pain in Patients With Brain Damage
November 2, 2020 updated by: MinYoung Kim, MD, PhD, Bundang CHA Hospital
The Effects of Extracorporeal Shockwave Therapy (ESWT) for Shoulder Pain in Patients With Brain Damage
This study aimed to investigate the efficacy and safety of extracorporeal shockwave therapy (ESWT) for upper extremity pain related to spasticity in patients with spinal cord injury.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
6 times of ESWT (3,000 pulses per time, low energy under 0.3 mJ/mm^2, tolerable range) on subscapularis and lesser and greater tuberlces of humerus to reduce pain in patients with brain damage
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: MinYoung Kim, MD, PhD
- Phone Number: 82-30-780-6281
- Email: kmin@cha.ac.kr
Study Locations
-
-
-
Seongnam, Korea, Republic of, 13496
- Recruiting
- Department of Rehabilitation Medicine, CHA Bundang Medical Center
-
Contact:
- MinYoung Kim, MD,PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Brain damaged patient confirmed in the brain image
- 1 month after brain damage
- Pain in hemiplegic shoulder areas more than 4 points on the numerical scale (NRS)
- Cognitive functions that can clearly point out NRS with more than 15 points in the mini mental state examination (MMSE)
- Age: 20 and older
- Person who has agreed in writing to decide his or her participation and comply with the precautions
Exclusion Criteria:
- Pain due to trauma
- Injection treatments two weeks before participating in the study
- Severe coagulopathy (excluding antiplatelet use)
- Impaired cognition
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental group
3,000 pulses per time, low energy under 0.3 mJ/mm^2, tolerable range
|
Extracorporeal shockwave therapy 6 times during 2 weeks
|
Sham Comparator: Control group
Sham therapy
|
Extracorporeal shockwave therapy 6 times during 2 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Numerical rating scale (NRS)
Time Frame: Up to 4 weeks (baseline, after each treatment during 2 weeks, 2 weeks + 1 day, 4 weeks)
|
Pain intensity (0-10, ordinal scale)
|
Up to 4 weeks (baseline, after each treatment during 2 weeks, 2 weeks + 1 day, 4 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Shoulder Pain and Disability Index (SPADI)
Time Frame: Up to 4 weeks (baseline, 2 weeks + 1 day, 4 weeks)
|
Scoring scale consist of 5 pain scale and 8 disability scale, in %, 0 (best) to 100 (worst)
|
Up to 4 weeks (baseline, 2 weeks + 1 day, 4 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: MinYoung Kim, MD, PhD, Department of Rehabilitation Medicine, CHA Bundang Medical Center, CHA University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 29, 2020
Primary Completion (Anticipated)
October 31, 2020
Study Completion (Anticipated)
February 5, 2021
Study Registration Dates
First Submitted
March 21, 2020
First Submitted That Met QC Criteria
March 21, 2020
First Posted (Actual)
March 24, 2020
Study Record Updates
Last Update Posted (Actual)
November 4, 2020
Last Update Submitted That Met QC Criteria
November 2, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Pain
- Neurologic Manifestations
- Wounds and Injuries
- Joint Diseases
- Musculoskeletal Diseases
- Craniocerebral Trauma
- Trauma, Nervous System
- Signs and Symptoms, Respiratory
- Arthralgia
- Hypoxia
- Brain Injuries
- Shoulder Pain
- Hypoxia, Brain
Other Study ID Numbers
- ESWTbraindamage
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Sharing Supporting Information Type
- Study Protocol
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on Extracorporeal shockwave therapy
-
Hyunjoong KimNot yet recruitingHealthyKorea, Republic of
-
Loewenstein HospitalUniversity of Melbourne; James Cook University, Queensland, Australia; MedispecCompleted
-
University of Sao Paulo General HospitalRecruitingTemporomandibular Joint Disorders | Extracorporeal Shockwave TherapyBrazil
-
Hull University Teaching Hospitals NHS TrustUniversity of HullActive, not recruitingPeripheral Vascular DiseaseUnited Kingdom
-
Medical University of ViennaCompleted
-
Istituto Auxologico ItalianoRecruitingStroke | Hemiplegia | Hemiparesis | Spasticity as Sequela of Stroke | Upper Limb HypertoniaItaly
-
Guadarrama HospitalPuerta de Hierro University HospitalRecruiting
-
Hull University Teaching Hospitals NHS TrustRecruiting
-
Odense University HospitalUnknownTransplant DysfunctionDenmark
-
AUVACompleted